The document discusses the company's financial performance in the last quarter of 2022. Revenue was up 10% compared to the same period last year, driven primarily by growth in the technology and healthcare sectors. However, expenses also rose at a higher-than-expected rate due to inflation and supply chain issues, resulting in net income being down 5% year-over-year.